# Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy

> **NCT03620513** · PHASE4 · COMPLETED · sponsor: **Lumbini Medical College** · enrollment: 160 (actual)

## Conditions studied

- Throat Disorder

## Interventions

- **DRUG:** Decongestant (oxymetazoline 0.05%)
- **DRUG:** Anesthesia (Lidocaine 15%)
- **DRUG:** Decongestants and Anesthesia (oxymetazoline and lidocaine)
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT03620513
- **Lead sponsor:** Lumbini Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-01
- **Primary completion:** 2019-01-16
- **Final completion:** 2019-02-16
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03620513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03620513, "Pretreatment to Reduce Pain and Discomfort During Fiberoptic Nasal Pharyngoscopy and Laryngoscopy". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03620513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*